XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Financial Instruments - Narratives (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Fair Value of Financial Instruments            
Fair value of contingent consideration $ 6,788,000     $ 6,788,000   $ 6,274,000
In-process R&D, carrying value and fair value 18,600,000     18,600,000   $ 19,800,000
In-process R&D impairment 1,300,000     1,300,000    
Goodwill, at carrying value 1,500,000 $ 5,500,000   1,500,000    
Goodwill, fair value 0 1,500,000   0    
Goodwill impairment 1,526,000 $ 4,000,000.0   5,594,000    
V C N            
Fair Value of Financial Instruments            
Additional consideration related to the achievement of certain milestones       70,200,000    
Amount to be paid due to approval     $ 3,250,000      
Fair value of contingent consideration 6,800,000     6,800,000    
Operating expense relating to fair value adjustment $ (587,000)   $ 1,600,000 $ (514,000) $ 1,000,000.0